WellCare Health Plans (NYSE:WCG) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $9.55-9.85 for the period, compared to the Thomson Reuters consensus estimate of $9.34.
A number of research firms have recently issued reports on WCG. Morgan Stanley raised their price target on shares of WellCare Health Plans from $214.00 to $220.00 and gave the stock an equal weight rating in a research report on Wednesday, February 7th. Cantor Fitzgerald reiterated a buy rating and issued a $235.00 price objective on shares of WellCare Health Plans in a research report on Tuesday, February 6th. Cowen reiterated an outperform rating and issued a $250.00 price objective on shares of WellCare Health Plans in a research report on Tuesday, January 23rd. Zacks Investment Research cut shares of WellCare Health Plans from a strong-buy rating to a hold rating in a research note on Saturday, January 6th. Finally, Goldman Sachs Group started coverage on shares of WellCare Health Plans in a research note on Wednesday, January 3rd. They issued a buy rating and a $255.00 price objective on the stock. Eight research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock presently has a consensus rating of Buy and an average price target of $218.21.
WellCare Health Plans (NYSE:WCG) traded up $1.06 during mid-day trading on Wednesday, hitting $195.39. 3,792 shares of the company traded hands, compared to its average volume of 345,069. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.28 and a current ratio of 1.31. The firm has a market capitalization of $8,678.42, a PE ratio of 23.39, a P/E/G ratio of 1.25 and a beta of 0.82. WellCare Health Plans has a twelve month low of $136.23 and a twelve month high of $221.75.
WellCare Health Plans (NYSE:WCG) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.21 by $0.11. The business had revenue of $4.35 billion during the quarter, compared to analysts’ expectations of $4.32 billion. WellCare Health Plans had a net margin of 2.20% and a return on equity of 17.10%. The firm’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period last year, the company posted $1.03 earnings per share. analysts predict that WellCare Health Plans will post 9.8 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/02/14/wellcare-health-plans-wcg-issues-fy18-earnings-guidance.html.
About WellCare Health Plans
WellCare Health Plans, Inc is a managed care company. The Company focuses on government-sponsored managed care services, primarily through Medicaid, Medicare Advantage (MA) and Medicare Prescription Drug Plans (PDPs), to families, children, seniors and individuals with medical needs. The Company operates through three segments: Medicaid Health Plans, Medicare Health Plans and Medicare PDPs.
Receive News & Ratings for WellCare Health Plans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WellCare Health Plans and related companies with MarketBeat.com's FREE daily email newsletter.